UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

The Lancet (British edition), 2017-03, Vol.389 (10075), p.1218-1228

2017

Volltextzugriff (PDF)

Crohn's disease associated strictures

Journal of gastroenterology and hepatology, 2018-05, Vol.33 (5), p.998-1008

2018

Volltextzugriff (PDF)

Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature

World journal of gastroenterology : WJG, 2014-07, Vol.20 (27), p.8783-8789

2014

Volltextzugriff (PDF)

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2019-04, Vol.156 (5), p.1440-1454.e2

2019

Volltextzugriff (PDF)

Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD

Alimentary pharmacology & therapeutics, 2024-06, Vol.59 (12), p.1644-1645

2024

Volltextzugriff (PDF)

Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing

Gastroenterology (New York, N.Y. 1943), 2017-09, Vol.153 (3), p.723-731.e1

2017

Volltextzugriff (PDF)

Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study

Alimentary pharmacology & therapeutics, 2021-08, Vol.54 (3), p.292-301

2021

Volltextzugriff (PDF)

The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease

Current opinion in pharmacology, 2020-12, Vol.55, p.8-16

2020

Volltextzugriff (PDF)

Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer

Journal of gastroenterology and hepatology, 2010-01, Vol.25 (1), p.33-42

2010

Volltextzugriff (PDF)

Risk mitigation in Crohn's disease and ulcerative colitis: Session four summary

Journal of gastroenterology and hepatology, 2021-04, Vol.36 (S1), p.27-28

Leong, Rupert W

2021

Volltextzugriff (PDF)

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases

Proteomes, 2018-03, Vol.6 (2), p.17

2018

Volltextzugriff (PDF)

Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis

Expert opinion on drug safety, 2021-03, Vol.20 (3), p.275-292

2021

Volltextzugriff (PDF)

Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension

Journal of Crohn's and colitis, 2022-08, Vol.16 (8), p.1222-1234

2022

Volltextzugriff (PDF)

Margin Clearance and Outcome in Resected Pancreatic Cancer

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2855-2862

2009

Volltextzugriff (PDF)

Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease

Molecular & cellular proteomics, 2017-07, Vol.16 (7), p.1244-1257

2017

Volltextzugriff (PDF)

Combination Therapy of Immunomodulators With Non–Anti-Tumor Necrosis Factor Agents in Inflammatory Bowel Disease: Need More Evidence?

Clinical gastroenterology and hepatology, 2022-03, Vol.20 (3), p.e640-e641

2022

Volltextzugriff (PDF)

A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy

Clinical gastroenterology and hepatology, 2014, Vol.12 (1), p.64-71

2014

Volltextzugriff (PDF)

Low-dose IL-2 may enhance the effect of vedolizumab

Scandinavian journal of gastroenterology, 2022-11, Vol.57 (11), p.1404-1405

2022

Volltextzugriff (PDF)

The significance of granulomas in Crohn's disease and inflammatory bowel disease epidemiology in Asia

Journal of gastroenterology and hepatology, 2020-04, Vol.35 (4), p.523-524

Leong, Rupert W L

2020

Volltextzugriff (PDF)

Letter: Thioguanine, an underutilised option in inflammatory bowel disease?

Alimentary pharmacology & therapeutics, 2024-04, Vol.59 (8), p.1009-1010

2024

Volltextzugriff (PDF)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2024-06, Vol.59 (11), p.1312-1334

2024

Volltextzugriff (PDF)

An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases

Journal of gastroenterology and hepatology, 2022-02, Vol.37 (2), p.246-255

2022

Volltextzugriff (PDF)

Ulcerative Colitis and Cytomegalovirus Infection: From A to Z

Journal of Crohn's and colitis, 2020-09, Vol.14 (8), p.1162-1171

2020

Volltextzugriff (PDF)

Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective

Molecular & cellular proteomics, 2016-01, Vol.15 (1), p.256-265

2016

Volltextzugriff (PDF)

1 – 25 von 378

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(353)
Mit Volltextzugriff
(314)

Publikationsform

Sprache

Englisch
(378)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

Crohn's disease associated strictures

Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD

Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing

Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study

The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease

Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer

Risk mitigation in Crohn's disease and ulcerative colitis: Session four summary

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases

Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis

Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension

Margin Clearance and Outcome in Resected Pancreatic Cancer

Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease

Combination Therapy of Immunomodulators With Non–Anti-Tumor Necrosis Factor Agents in Inflammatory Bowel Disease: Need More Evidence?

A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy

Low-dose IL-2 may enhance the effect of vedolizumab

The significance of granulomas in Crohn's disease and inflammatory bowel disease epidemiology in Asia

Letter: Thioguanine, an underutilised option in inflammatory bowel disease?

Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease

An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases

Ulcerative Colitis and Cytomegalovirus Infection: From A to Z

Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective

Suchergebnisse filtern